Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer

Recruiting N/A Interventional Study
NSCLC (Advanced Non-small Cell Lung Cancer) Adaptive Radiotherapy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Locally advanced non-small cell lung cancer (LA-NSCLC) patients could benefit in overall and progression-free survival from regular dosimetric treatment plan adaptations during radiotherapy. This is known as adaptive radiotherapy (ART). However, implementing an adaptive radiotherapy workflow presents a highly cumbersome process. First, repeated planning-CT imaging during treatment is required, whi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures 2. Patients diagnosed with non-small-cell lung cancer 3. Locally advanced disease (≥Stage III) 4. Treated with sequential or co…
Contacts

Wouter Crijns, Prof. Dr.

+3216341453

wouter.crijns@uzleuven.be

CONTACT

Maarten Lambrecht, Prof. Dr.

+3216347629

maarten.lambrecht@uzleuven.be

CONTACT